A new 5-HT3 receptor ligand.: II.: Structure-activity analysis of 5-HT3 receptor agonist action in the gut

被引:0
作者
Yamada, M [1 ]
Sato, Y [1 ]
Kobayashi, K [1 ]
Konno, F [1 ]
Soneda, T [1 ]
Watanabe, T [1 ]
机构
[1] Meiji Seika Kaisha Ltd, Pharmaceut Res Ctr, Kohoku Ku, Yokohama, Kanagawa 222, Japan
关键词
1-allyl-1-methyl-4-(2-benzoxazolyl)piperazinium iodide (CP2289); 5-HT3; receptor; agonist;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several modified 2-piperazinyl benzoxazole derivatives, which exhibit an agonistic effect on gastrointestinal motility, were synthesized and their effects on the contraction of guinea-pig ileum were examined, The quaternary piperazinyl benzoxazole structure has a restricted conformation and stereostructure compared to those of the other 5-HT3 receptor agonists, serotonin and meta-chlorophenylbiguanide. The mutual positions of the aromatic ring, nitrogen atom and terminal amine are considered to form the pharmacophore of the 5-HT3 receptor agonist in the gut. In the serotonin-evoked reflex bradycardia [Bezold-Jarisch (B-J) reflex] inhibition test using rats the B-J reflex-inducing ratio was different for each synthesized compound. These results suggest that, in these 5-HT3 receptor agonists, the substituents of the benzoxazole ring influence the B-J reflex-inducing activity in rats.
引用
收藏
页码:445 / 451
页数:7
相关论文
共 50 条
  • [41] Regulatory molecules for the 5-HT3 receptor ion channel gating system
    Yoshida, Satoshi
    Watanabe, Takashi
    Sato, Yasuo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (10) : 3515 - 3523
  • [42] Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function
    Rojas, Camilo
    Thomas, Ajit G.
    Alt, Jesse
    Stathis, Marigo
    Zhang, Jie
    Rubenstein, Edward B.
    Sebastiani, Silvia
    Cantoreggi, Sergio
    Slusher, Barbara S.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 626 (2-3) : 193 - 199
  • [43] Agonist and antagonist effects of apomorphine enantiomers on 5-HT3 receptors
    van Hooft, JA
    Vijverberg, HPM
    NEUROPHARMACOLOGY, 1998, 37 (02) : 259 - 264
  • [44] 5-HT3 RECEPTOR ANTAGONISTS, A NEW APPROACH IN EMESIS - A REVIEW OF ONDANSETRON, GRANISETRON AND TROPISETRON
    SEYNAEVE, C
    VERWEIJ, J
    DEMULDER, PHM
    ANTI-CANCER DRUGS, 1991, 2 (04) : 343 - 355
  • [45] Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression
    Krzywkowski, Karen
    Jensen, Anders A.
    Connolly, Christopher N.
    Brauner-Osborne, Hans
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (04) : 255 - 266
  • [46] Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: Importance of glutamate 106
    Boess, FG
    Steward, LJ
    Steele, JA
    Liu, D
    Reid, J
    Glencorse, TA
    Martin, IL
    NEUROPHARMACOLOGY, 1997, 36 (4-5) : 637 - 647
  • [47] Native serotonin 5-HT3 receptors expressed in Xenopus oocytes differ from homopentameric 5-HT3 receptors
    vanHooft, JA
    Kreikamp, AP
    Vijverberg, HPM
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 (03) : 1318 - 1321
  • [48] Phosphorylation of the 5-Hydroxytryptamine3 (5-HT3) receptor expressed in HEK293 cells
    Lankiewicz, S
    Hüser, MB
    Heumann, R
    Hatt, H
    Gisselmann, G
    RECEPTORS & CHANNELS, 2000, 7 (01) : 9 - 15
  • [49] Computational analysis of ligand recognition sites of homo- and heteropentameric 5-HT3 receptors
    Barbosa, Armenio J. Moura
    De Rienzo, Francesca
    Ramos, Maria J.
    Menziani, Maria Cristina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (11) : 4746 - 4760
  • [50] EFFECTS OF 5-HT3 RECEPTOR ANTAGONISTS ON NEUROLEPTIC-INDUCED CATALEPSY IN MICE
    SILVA, SR
    FUTURONETO, HA
    PIRES, JGP
    NEUROPHARMACOLOGY, 1995, 34 (01) : 97 - 99